ANGEL LUIS
GUERRERO PERAL
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Instituto de Investigación Sanitaria Aragón
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Aragón (6)
2024
-
Evaluation of the burden of migraine on the partner's lifestyle
Neurologia, Vol. 39, Núm. 9, pp. 810-819
2023
-
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Journal of Headache and Pain, Vol. 24, Núm. 1
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
2021
-
Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092
-
Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine
Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091
2020
-
Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives
Neurologia, Vol. 35, Núm. 6, pp. 372-380